These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8352567)

  • 1. Effects of serine protease inhibitor FOY-305 and heparin on the growth of squamous cell carcinoma.
    Ohkoshi M; Akagawa T; Nakajima M
    Anticancer Res; 1993; 13(4):963-6. PubMed ID: 8352567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the synthetic protease inhibitor [N,N-dimethylcarbamoyl-methyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on carcinogenesis by 3-methylcholanthrene in mouse skin.
    Ohkoshi M; Fujii S
    J Natl Cancer Inst; 1983 Nov; 71(5):1053-7. PubMed ID: 6580482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of mouse autochthonous skin cancer by oral administration of new serine protease inhibitor ONO-3403.
    Ohkoshi M; Okuda S
    Anticancer Res; 2002; 22(2A):821-3. PubMed ID: 12014657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protease inhibitors as anticancer chemotherapy--experimental and clinical studies].
    Ohkoshi M
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):417-30. PubMed ID: 7887633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of mouse skin tumor by serine protease inhibitor ONO-3403.
    Ohkoshi M; Okuda S
    Anticancer Res; 2001; 21(3B):1803-8. PubMed ID: 11497262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral administration of protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on the growth of 3-methylcholanthrene-induced carcinoma in mice.
    Ohkoshi M; Fujii S
    Gan; 1982 Feb; 73(1):108-10. PubMed ID: 7117738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of growth of 3-methylcholanthrene-induced mouse skin tumor by protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate.
    Ohkoshi M
    Gan; 1981 Dec; 72(6):959-64. PubMed ID: 7341342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimetastatic activity of a synthetic serine protease inhibitor, FOY-305 (Foypan).
    Ohkoshi M; Sasaki Y
    In Vivo; 2005; 19(1):133-6. PubMed ID: 15796165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on the growth of mouse skin carcinoma in the rapid growing stage.
    Ohkoshi M; Fujii S
    J Dermatol; 1984 Feb; 11(1):21-4. PubMed ID: 6376571
    [No Abstract]   [Full Text] [Related]  

  • 10. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma.
    Chen CL; Wang SD; Zeng ZY; Lin KJ; Kao ST; Tani T; Yu CK; Wang JY
    J Allergy Clin Immunol; 2006 Jul; 118(1):105-12. PubMed ID: 16815145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory effect of FOY-305 on liver metastasis of the pancreatic cancer].
    Ohta T; Futagami F; Arakawa H; Tsukioka Y; Kitagawa H; Kayahara M; Nagakawa T; Miyazaki I
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1669-72. PubMed ID: 8886041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of the synthetic proteinase inhibitor, FOY, on hypercoagulability after surgery for esophageal carcinoma].
    Usuba A; Motoki R; Koizumi Y; Oishi A; Endo Y; Konno O; Inoue H
    Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):931-41. PubMed ID: 2122227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-invasive activity of synthetic serine protease inhibitors and its combined effect with a matrix metalloproteinase inhibitor.
    Ikeda T; Murakami K; Hayakawa Y; Fujii H; Ohkoshi M; Saiki I
    Anticancer Res; 1998; 18(6A):4259-65. PubMed ID: 9891476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aprotinin on growth of 3-methylcholanthrene-induced squamous cell-carcinoma in mice.
    Ohkoshi M
    Gan; 1980 Apr; 71(2):246-50. PubMed ID: 6162702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-carcinogenic effects of a serine protease inhibitor (FOY-305) through the suppression of neutral serine protease activity during chemical hepatocarcinogenesis in rats.
    Yamauchi Y; Kobayashi M; Watanabe A
    Hiroshima J Med Sci; 1987 Mar; 36(1):81-7. PubMed ID: 2884198
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutrophil elastase inhibitor (ONO-5046-Na) inhibits the growth of human lung cancer cell lines transplanted into severe combined immunodeficiency (scid) mice.
    Inada M; Yamashita J; Ogawa M
    Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):229-32. PubMed ID: 9344234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs.
    Luh SP; Tsai CC; Shau WY; Chen JS; Kuo SH; Lin-Shiau SY; Lee YC
    J Surg Res; 1999 Dec; 87(2):152-63. PubMed ID: 10600344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling of tumour--host coexistence In vitro in the presence of serine protease inhibitors.
    Engi H; Gyémánt N; Ohkoshi M; Amaral L; Molnár J
    In Vivo; 2009; 23(5):711-5. PubMed ID: 19779105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of epidermal carcinoma formation by prolactin in mice.
    Lupulescu A
    J Natl Cancer Inst; 1985 Jun; 74(6):1335-46. PubMed ID: 3858600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
    Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
    Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.